![William John Fraser Goldie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in William John Fraser Goldie first degree
Entity | Entity type | Industry | |
---|---|---|---|
OxThera AB
![]() OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.
2
| Holding Company | Pharmaceuticals: Generic | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to William John Fraser Goldie via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Uppsala | College/University | Masters Business Admin Undergraduate Degree | |
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
![]() Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Octapharma AB
![]() Octapharma AB Pharmaceuticals: MajorHealth Technology Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Metcon Medicin AB
![]() Metcon Medicin AB Pharmaceuticals: MajorHealth Technology MetCon Medicin AB develops and manufactures pharmaceutical products. Its products are used for oral administration and stabilizing blood sugar levels. The company's products are used for the treatment of diabetes and other metabolic diseases. MetCon Medicin was founded by Dr. Ulf Smith and Dr. Mats Lake in 1999 and is headquartered in Lidingo, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cobra Biologics Holding AB
![]() Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Royal Institute of Technology | College/University | Graduate Degree | |
Biosource Europe AB | Director/Board Member | ||
Cobra Biologics Ltd.
![]() Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Epicyt Pharma AB
![]() Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA. | Pharmaceuticals: Major | Chairman | |
BIOTAGE AB | Medical Specialties | Director of Finance/CFO | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO |
Statistics
International
Sweden | 15 |
United States | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 12 |
Consumer Services | 3 |
Finance | 2 |
Commercial Services | 2 |
Operational
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Director of Finance/CFO | 4 |
Public Communications Contact | 3 |
Chief Executive Officer | 2 |
Most connected contacts
Insiders | |
---|---|
Edith Olga Elisabeth Lindner | 15 |
Mats-Olof Wallin | 5 |
- Stock Market
- Insiders
- William John Fraser Goldie
- Company connections